MEN1 and ovarian neoplasm: In summary, our results demonstrate that genetic background alters the phenotypic expression of PNETs and pituitary, adrenal and ovarian tumours due to loss of Men1, thereby providing a model that will help to improve our understanding of the clinical manifestations of MEN1 mutations in different patients.